Author

V. Chaturvedi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 8

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 8 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Research Focus:benchmarking· 1 Organism:C. elegans· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:variant calling· 1

Frequent Co-Authors

S. Chaturvedi· 7 shared B. O'Brien· 3 shared L. Leach· 2 shared Y. C. Zhu· 2 shared Y. Zhu· 2 shared A. Clark· 1 shared A. L. Greninger· 1 shared A. Russell· 1 shared

Activity by Year

2017-2020 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

7 shared papersMicrobiology

S. Chaturvedi

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

Pan-resistant Candida auris: New York Sub-cluster Susceptible to Antifungal Combinations

B. O'Brien, J. Liang, S. Chaturvedi, J. Jacobs, V. Chaturvedi

The paper shows that pan-resistant Candida auris strains from a New York outbreak are susceptible to antifungal combinations, despite having mutations in multiple drug targets.

bioRxiv · Jun 8, 2020Microbiology

Evaluation of in vitro activity of manogepix against multidrug-resistant and pan-resistant Candida auris from the New York Outbreak

Y. Zhu, S. Kilburn, M. Kapoor, S. Chaturvedi, K. J. Shaw, V. Chaturvedi

This study evaluates the in vitro activity of manogepix against multidrug-resistant and pan-resistant Candida auris isolates from a New York outbreak, showing it is significantly more active than existing antifungals.

bioRxiv · Jun 2, 2020Microbiology

In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak

B. O'Brien, S. Chaturvedi, V. Chaturvedi

This study evaluates two-drug antifungal combinations against multidrug-resistant Candida auris isolates, finding that flucytosine combinations are most effective in vitro.

bioRxiv · Oct 31, 2019Microbiology

In vitro Efficacy of Novel Glucan Synthase Inhibitor, Ibrexafungerp (SCY-078), Against Multidrug- and Pan-resistant Candida auris Isolates from the Outbreak in New York

Y. C. Zhu, S. A. Barat, K. Borroto-Esoda, D. Angulo, S. Chaturvedi, V. Chaturvedi

The paper evaluates the efficacy of the novel glucan synthase inhibitor Ibrexafungerp against multidrug-resistant Candida auris isolates from a New York outbreak, finding it effective with low MIC50 values.

bioRxiv · Oct 21, 2019Microbiology

Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018-Impact and Lessons Learned

Y. C. Zhu, B. O'Brien, L. Leach, A. Clark, M. Bates, E. Adams, B. Ostrowsky, M. Quinn, E. Dufort, K. Southwick, R. Erazo, V. B. Haley, C. Bucher, V. Chaturvedi, R. J. Limberger, , S. Chaturvedi

This study analyzes a C. auris outbreak in New York, identifying factors contributing to its spread and demonstrating the effectiveness of new detection methods.

bioRxiv · Sep 6, 2019Microbiology

A rapid and automated sample-to-result Candida auris real-time PCR assay for high throughput testing of surveillance samples with BD MAX™ open system

L. Leach, A. Russell, Y. Zhu, S. Chaturvedi, V. Chaturvedi

This paper develops an automated real-time PCR assay for rapid detection of Candida auris using the BD MAX system, achieving high sensitivity and specificity in clinical samples.

bioRxiv · Aug 5, 2019Microbiology

Characterization of novel Chrysosporium morrisgordonii sp. nov., from bat white-nose syndrome (WNS) affected mines, northeastern United States

T. Zhang, P. Ren, X. Li, S. Chaturvedi, V. Chaturvedi

The paper describes the characterization of a new fungal species, Chrysosporium morrisgordonii, isolated from bat white-nose syndrome affected mines.

bioRxiv · Apr 4, 2019 · PreprintMicrobiology

Validation and Implementation of CLIA-Compliant Whole Genome Sequencing (WGS) in Public Health Laboratory

V. K. Kozyreva, C.-L. Truong, A. L. Greninger, J. Crandall, R. Mukhopadhyay, V. Chaturvedi

This paper validates whole genome sequencing in public health labs according to CLIA guidelines and develops tools for quality assurance and reporting.

bioRxiv · Feb 8, 2017Microbiology